Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Zhongchao Inc. Establishes Chongqing Xinjiang Pharmaceutical Co., Ltd. to Improve Patient Access to Medications 2022-09-28 21:18
ASTRUM-005: The first immunotherapy clinical study of SCLC published in JAMA, one of the top medical journals in the world 2022-09-28 21:00
ICHNOS SCIENCES ANNOUNCES INITIATION OF FIRST-IN-HUMAN STUDY FOR ISB 1442 2022-09-28 20:30
ABILITY DIABETES GLOBAL - A Landmark RCT in the field of PCI for patients with DM, completes Enrolment 2022-09-28 20:29
Samsung Biologics Earns Gold Rating from EcoVadis for Its Sustainability Efforts 2022-09-28 19:00
The IND application of Biosyngen BRG01 Therapy was accepted by CDE 2022-09-28 18:05
Biosyngen Gives Cell Therapy GMP Capabilities in Singapore A Boost 2022-09-28 17:34
Vernalis Research, a fully owned subsidiary of HitGen Inc., and Contera Pharma A/S announce a strategic collaboration in the field of RNA-targeting small molecules in neurology 2022-09-28 16:00
Pharming Announces US FDA Acceptance for Priority Review of its New Drug Application for Leniolisib 2022-09-28 13:00
Chugai Pharma Taiwan Awarded at the Asia Responsible Enterprise Awards 2022 for 'Cycling for Charity' under Social Empowerment Category 2022-09-28 12:30
ETANA HAS SECURED B ROUND FINANCING 2022-09-28 09:00
Ascletis Announces Dosing of the First Patient in the Phase IIb Expansion Cohort of ASC22 (Envafolimab) for Chronic Hepatitis B Functional Cure 2022-09-28 08:10
Chinese NMPA Approves Study of Telix Kidney Cancer Imaging Candidate 2022-09-28 06:50
First Patient in Australia Dosed with Illuccix® - Telix's Approved Prostate Cancer Imaging Agent 2022-09-28 05:00
Harbour BioMed Announces First Subject Dosed in Phase I Study of Next-Gen Anti-TSLP Fully Human Monoclonal Antibody 2022-09-27 21:40
TargEDys and Inoliva announce they have entered a distribution partnership to bring Satylia® to Turkey 2022-09-27 17:15
Angel Pharmaceuticals Announces Approval of IND Application for Phase 1/1b Clinical Trial of Mupadolimab (Anti-CD73) in China 2022-09-27 08:30
Sciwind Biosciences and SynerK Enter into Research Partnership to Discover and Develop Novel siRNA Therapeutics 2022-09-27 08:00
First Patient Enrolled in ProstACT TARGET Study 2022-09-27 05:00
Fosun Pharma and MAIA Pharmaceuticals Jointly Announce the Successful Commercialization of Only FDA Approved 20ml Sodium Phenylacetate and Sodium Benzoate (SPSB) Liquid Product 2022-09-26 22:13
1 110 111 112 113 114 375